Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
0.00 (0.00%)
Aug 7, 2026, 4:00 PM EST
Revium Rx. Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Net Income | -13.54 | -13.45 | -3.51 | -0.99 | -1.21 | -0.1 |
Depreciation & Amortization | 0.01 | 0.01 | 0 | 0 | 0 | - |
Asset Writedown & Restructuring Costs | 9.68 | 9.68 | - | - | - | - |
Stock-Based Compensation | 0.28 | 0.62 | 2 | 0.21 | 0.29 | - |
Other Operating Activities | 0.39 | 0.37 | -0 | - | 0.06 | 0 |
Change in Accounts Receivable | - | - | - | - | - | 0.27 |
Change in Inventory | - | - | - | - | - | 0.46 |
Change in Accounts Payable | 0.09 | 0.02 | 0.03 | -0.26 | -0 | 0.07 |
Change in Other Net Operating Assets | 0.36 | 0.22 | 0.27 | 0.03 | 0.04 | 2.53 |
Operating Cash Flow | -2.72 | -2.53 | -1.21 | -1.01 | -0.82 | 3.23 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Capital Expenditures | -0.01 | -0.01 | -0 | -0 | -0 | - |
Sale of Property, Plant & Equipment | 0 | - | - | - | - | 2 |
Cash Acquisitions | - | - | 0.73 | - | - | - |
Investment in Securities | -0.23 | 0.98 | -2 | -0.01 | - | - |
Other Investing Activities | -0.05 | -0.03 | - | - | - | - |
Investing Cash Flow | -0.28 | 0.94 | -1.27 | -0.01 | -0 | 2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Long-Term Debt Repaid | - | - | - | - | - | -0.11 |
Net Debt Issued (Repaid) | - | - | - | - | - | -0.11 |
Issuance of Common Stock | - | - | 0 | 1.59 | 0.38 | - |
Repurchase of Common Stock | - | - | - | - | - | -0.01 |
Other Financing Activities | - | - | - | -0.2 | - | -5.13 |
Financing Cash Flow | - | - | 0 | 1.39 | 0.38 | -5.25 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Net Cash Flow | -2.99 | -1.59 | -2.48 | 0.37 | -0.45 | -0.02 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Free Cash Flow | -2.72 | -2.54 | -1.21 | -1.02 | -0.82 | 3.23 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | - | 491.85% |
Free Cash Flow Per Share | -0.04 | -0.04 | -0.05 | -0.04 | -0.03 | 55.51 |
Levered Free Cash Flow | -1.08 | -0.95 | 0.3 | -0.66 | - | 0.18 |
Unlevered Free Cash Flow | -1.06 | -0.95 | 0.3 | -0.66 | - | 0.18 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2009 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '09 Dec 31, 2009 |
Change in Working Capital | 0.46 | 0.24 | 0.3 | -0.23 | 0.04 | 3.34 |